TrialHuman vaccines & immunotherapeutics2017

A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants.

Lalitendu Mohanty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.